Development and Pretesting of Prescription Opioid Misuse Prevention Messages: Results and Implications for Practice

Overview of attention for article published in Health Communication, September 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

twitter: 11 X users

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 7 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 18 X posts from 11 X users, with an upper bound of 8,717 followers.

Dr. Holli Seitz, director of the SSRC's Message Lab, is a co-author on this publication. ⬇️🔖

02 Nov 2022

Reply Repost Favourite

RT @UMMC_MCCTR: Dr. David Buys, an MCCTR Steering Committee member & Assoc. Professor of Food Science, Nutrition and Health Promotion @MSUE…

02 Nov 2022

Reply Repost Favourite

RT @UMMC_MCCTR: Dr. David Buys, an MCCTR Steering Committee member & Assoc. Professor of Food Science, Nutrition and Health Promotion @MSUE…

02 Nov 2022

Reply Repost Favourite

Dr. David Buys, an MCCTR Steering Committee member & Assoc. Professor of Food Science, Nutrition and Health Promotion @MSUExtService, reviews the efficacy of development and pretesting of prescription opioid misuse prevention messages: https://t.co/pew

02 Nov 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 14 additional X posts.